Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques

被引:4
|
作者
Jairam, Vikram [1 ]
Pasha, Saamir [2 ]
Soulos, Pamela R. [2 ]
Gross, Cary P. [2 ,3 ,4 ]
Yu, James B. [1 ,2 ]
Park, Henry S. [1 ,2 ]
Decker, Roy H. [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Therapeut Radiol, 15 York St,Hunter Bldg,CB328, New Haven, CT 06511 USA
[2] Yale Sch Med, Canc Outcomes Publ Policy & Effectiveness Res CO, New Haven, CT USA
[3] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT USA
[4] Yale Univ, Sch Med, Natl Clinician Scholars Program, New Haven, CT USA
关键词
Radiation techniques; Post-operative radiotherapy; Toxicity; Non small cell; INTENSITY-MODULATED RADIOTHERAPY; ELDERLY-PATIENTS; STAGE-IIIA; PNEUMONITIS; PREDICTORS; SURVIVAL; ASSOCIATION;
D O I
10.1016/j.lungcan.2021.09.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Post-operative radiation therapy (PORT) in locally advanced non-small cell lung cancer (LA-NSCLC) has historically been associated with toxicity. Conformal techniques like intensity modulated radiation therapy (IMRT) have the potential to reduce acute and long-term toxicity from radiation therapy. Among patients receiving PORT for LA-NSCLC, we identified factors associated with receipt of IMRT and evaluated the association between IMRT and toxicity. Methods: We queried the Surveillance, Epidemiology, and End Results (SEER)-Medicare database between January 1, 2006 to December 31, 2014 to identify patients diagnosed with Stage II or III NSCLC and who received upfront surgery and subsequent PORT. Baseline differences between patients receiving 3-dimentional conformal radiation therapy (3D-CRT) and IMRT were assessed using the chi-squared test for proportions and the t-test for means. Multivariable logistic regression was used to identify predictors of receipt of IMRT and pulmonary, esophageal, and cardiac toxicity. Propensity-score matching was employed to reduce the effect of known confounders. Results: A total of 620 patients met the inclusion criteria, among whom 441 (71.2%) received 3D-CRT and 179 (28.8%) received IMRT. The mean age of the cohort was 73.9 years and 54.7% were male. The proportion of patients receiving IMRT increased from 6.2% in 2006 to 41.4% in 2014 (P < 0.001). IMRT was not associated with decreased pulmonary (OR 0.89; 95% CI, 0.62-1.29), esophageal (OR 1.09; 95% CI, 0.0.75-1.58), or cardiac toxicity (OR 1.02; 95% CI, 0.69-1.51). These findings held on propensity-score matching. Clinical risk factors including comorbidity and prior treatment history were associated with treatment toxicity. Conclusion: In a cohort of elderly patients, the use of IMRT in the setting of PORT for LA-NSCLC was not associated with a difference in toxicity compared to 3D-CRT. This finding suggests that outcomes from PORT may be independent of radiotherapy treatment technique.
引用
收藏
页码:171 / 179
页数:9
相关论文
共 50 条
  • [1] Post-Operative Radiation Therapy for Non-Small Cell Lung Cancer: A Comparison of Radiation Therapy Techniques
    Jairam, V.
    Pasha, S.
    Soulos, P. R.
    Gross, C. P.
    Yu, J. B.
    Park, H. S. M.
    Decker, R. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E130 - E130
  • [2] Proton therapy for post-operative radiation therapy of non-small cell lung cancer
    Shepherd, Annemarie Fernandes
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (02) : 205 - 209
  • [3] Tobacco Influence on Post-operative Radiation Therapy for Non-small Cell Lung Cancer
    Nguyen, S. K.
    Masson-Cote, L.
    Fortin, A.
    Dagnault, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S531 - S531
  • [4] Intensity modulated post-operative radiation therapy for locally advanced non-small cell lung cancer
    Rosenzweig, K
    Gupta, V
    Jackson, A
    Choy, H
    Yorke, E
    LUNG CANCER, 2005, 49 : S51 - S52
  • [5] Single Institution Experience of Proton and Photon Based Post-Operative Radiation Therapy for Non-Small Cell Lung Cancer
    Boyce-Fappiano, D.
    Nguyen, Q. N.
    Chapman, B. V.
    Allen, P. K.
    Gjyshi, O.
    Pezzi, T. A.
    De, B.
    Bronk, J. K.
    Liao, Z.
    Lin, S. H.
    Chang, J. Y.
    Gomez, D. R.
    Gandhi, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E97 - E97
  • [6] Post-Operative Radiation Therapy (PORT) in Completely Resected Non-Small-Cell Lung Cancer
    Yelena Krupitskaya
    Billy W. Loo
    Current Treatment Options in Oncology, 2008, 9 : 343 - 356
  • [7] Post-Operative Radiation Therapy (PORT) in Completely Resected Non-Small-Cell Lung Cancer
    Krupitskaya, Yelena
    Loo, Billy W., Jr.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2008, 9 (4-6) : 343 - 356
  • [8] Dose-Volume and Clinical Correlates of Radiation Pneumonitis in Non-Small Cell Lung Cancer Patients Treated with Post-Operative Radiation Therapy
    Iocolano, M.
    Jackson, A.
    Yorke, E. D.
    Pham, H.
    Dick-Godfrey, R.
    Wu, A. J.
    Rimner, A.
    Shepherd, A. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E685 - E686
  • [9] Post-operative radiation therapy in locally advanced non-small cell lung cancer and the impact of sequential versus concurrent chemotherapy
    Waddle, Mark R.
    Ko, Stephen
    Johnson, Margaret M.
    Lou, Yanyan
    Miller, Robert C.
    Harrell, Anna C.
    Trifiletti, Daniel M.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S171 - S175
  • [10] Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer
    Boyer, Matthew J.
    Gu, Lin
    Wang, Xiaofei
    Kelsey, Chris R.
    Yoo, David S.
    Onaitis, Mark W.
    Dunphy, Frank R.
    Crawford, Jeffrey
    Ready, Neal E.
    Salama, Joseph K.
    LUNG CANCER, 2016, 98 : 76 - 78